Sign inJoin waitlistJoin the waitlist

BM

Bryan McGill

Medical Director, Clinical Development, AveXis Inc · Washington University/B-JH/SLCH Consortium

Credentials: · · ·

History

Washington University/B-JH/SLCH Consortium
Present

Research

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
Nature Medicine · 2022 · 263 citations
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
Nature Medicine · 2022 · 236 citations
Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress
Neuron · 2008 · 215 citations

Huda Zoghbi
3 papers
Claudia Chiriboga
2 papers
Craig Zaidman
2 papers
HM
Hugh Mcmillan
2 papers
Jena Krueger
2 papers
Jennifer Kwon
2 papers
Jerry Mendell
2 papers
Julie Parsons
2 papers
KS
Kathryn Swoboda
2 papers
Kevin Strauss
2 papers
Perry Shieh
2 papers
Richard Finkel
2 papers